Natco Seeks emergency approval to launch Molnupiravir for Covid-19 in India

Molnupiravir was originally developed to treat influenza before US-based Merck initiated research to repurpose drug for use against SARS-CoV-2 virus.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3tNiW7T
via IFTTT